Orgenesis Inc. (ORGS)
NASDAQ: ORGS · IEX Real-Time Price · USD
0.700
0.00 (0.00%)
Jul 22, 2024, 10:02 AM EDT - Market open
Orgenesis Employees
Orgenesis had 146 employees as of December 31, 2023. The number of employees decreased by 21 or -12.57% compared to the previous year.
Employees
146
Change (1Y)
-21
Growth (1Y)
-12.57%
Revenue / Employee
$3,623
Profits / Employee
-$312,712
Market Cap
33.05M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nutex Health | 800 |
Exagen | 179 |
Retractable Technologies | 151 |
IRIDEX | 111 |
ReWalk Robotics | 108 |
ImmuCell | 79 |
Immuneering | 68 |
Quince Therapeutics | 32 |
ORGS News
- 2 months ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 3 months ago - Orgenesis Provides Year End Business Update - GlobeNewsWire
- 3 months ago - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility - GlobeNewsWire
- 4 months ago - Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference - GlobeNewsWire
- 4 months ago - Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes - GlobeNewsWire
- 5 months ago - Orgenesis Inc. Announces $2.3 Million Private Placement - GlobeNewsWire
- 5 months ago - Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing - GlobeNewsWire
- 6 months ago - Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic - GlobeNewsWire